Replies to post #115859 on Biotech Values

[bridgeofsighs]

Novo Nordisk should let Lilly run its trials for Victoza going forward.

Bydureon:
Duration-1 = -1.9% HbA1c,
Duration-2 = -1.5% HbA1c,
Duration-3 = -1.5% HbA1c,
Duration-4 = -1.5% HbA1c,
Duration-5 = -1.6% HbA1c,
Duration-6 = -1.3% HbA1c, Victoza -1.5% HbA1c,

Victoza:
Lead-1 = -1.1% HbA1c,
Lead-2 = -1.0% HbA1c,
Lead-3 = -1.1% HbA1c,
Lead-4 = -1.5% HbA1c,
Lead-5 = -1.3% HbA1c,
Lead-6 = -1.1% HbA1c,